TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT07929285: Cy-Tb for Detecting Mycobacterium Tuberculosis Infection in Indonesian Population

Sponsor: PT Bio Farma · Phase: PHASE2 · Area: INFECTIOUS_VACCINE · Target Enrollment: 350 pts

Competing Trials Overlap

2 Active Trials

Excess Burn Exposure

$9,408,000

Rescue Site Savings

+$6,203,400

Unlock Full NCT07929285 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07929285 Rescue Dossier →